enVVeno Medical Corporation — Quarterly Cash Flow (NASDAQ:NVNO) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 50.39 M44.95 M40.58 M36.58 M32.35 M Total liabilities 3.02 M2.79 M2.27 M3.52 M2.9 M Total equity 47.37 M42.16 M38.31 M33.06 M29.45 M Total liabilities & shareholders' equities 50.39 M44.95 M40.58 M36.58 M32.35 M Total debt ————— Net debt —————

뉴스

enVVeno Medical, 나스닥 규정 재충족 및 2800만 달러 현금 보유

enVVeno Medical regains Nasdaq compliance, reports $28 million cash

enVVeno Medical announces 1-for-35 reverse stock split

enVVeno Medical, 주주총회 정족수 요건 변경 위해 정관 개정

enVVeno Medical updates bylaws to revise stockholder quorum requirement

enVVeno Medical, FDA의 VenoValve 거부 결정 유지 후 주가 급락

enVVeno Medical stock plunges after FDA upholds rejection of VenoValve

Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher - Amaze Holdings (AMEX:AMZE), Cidara Therapeutics (NASDAQ:CDTX)

Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings - Applied Mat (NASDAQ:AMAT), Amaze Holdings (AMEX:AMZE)

Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Binah Capital Group (NASDAQ:BCG), Aspire Biopharma Hldgs (NASDAQ:ASBP)

enVVeno 메디컬, VenoValve 승인 FDA 거부

FDA rejects enVVeno Medical’s appeal for VenoValve approval